Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	2 Months Ended	9 Months Ended	15 Months Ended
	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2011
Cash Flows from Operating Activities
Net loss	$ (10,039)	$ (406,285)	$ (564,315)
Adjustments to reconcile net loss to net cash used in operating activities:
Dividend income earned on investments held in Trust Account		(17,498)	(21,824)
Interest income earned on investments held in Trust Account		(1,096)	(1,096)
Change in operating assets and liabilities
(Increase) decrease in prepaid expenses		43,644	(40,543)
(Increase) in deferred offering costs	(160,750)
Increase (decrease) in accrued expenses and other liabilities	150,000	(129,163)	(59,295)
Increase in franchise taxes payable		105,054	123,789
Net cash used in operating activities	(20,789)	(405,344)	(563,284)
Cash Flows from Investing Activities
Cash held in Trust Account			(40,400,000)
Cash Flows from Financing Activities
Proceeds from notes payable, stockholders	75,000		75,000
Payments of notes payable, stockholders			(75,000)
Proceeds from issuance of common stock to initial stockholders	25,000		25,000
Proceeds from public offering			40,000,000
Proceeds from issuance of warrants			2,280,000
Payment of offering costs			(1,192,034)
Advance from Sponsor			260,000
Repayment of advance from Sponsor		(260,000)	(260,000)
Net cash provided by (used in) financing activities	100,000	(260,000)	41,112,966
Net increase (decrease) in cash	79,211	(665,344)	149,682
Cash and cash equivalents at beginning of the period		815,026
Cash and cash equivalents at end of the period	79,211	149,682	149,682
Supplemental schedule of non-cash financial activities:
Accrual for offering costs and other expenses	150,000		128,432
Deferred underwriters' compensation			331,300
Deferred legal fees related to the offering			$ 100,000